Advertisement

Metoclopramide in Pregnancy: More Reassuring Safety Data — Physician’s First Watch

Medical News |
October 16, 2013

Metoclopramide in Pregnancy: More Reassuring Safety Data

By Amy Orciari Herman

A new study in JAMA adds to the growing evidence that metoclopramide (Reglan) may be safely used to treat severe nausea in pregnancy.

Examining Danish registries, researchers matched some 40,000 pregnancies in which metoclopramide prescriptions were dispensed to roughly 150,000 unexposed pregnancies. The incidence of overall major congenital malformations did not differ significantly between the groups (roughly 25 per 1000 births), nor did the incidence of 20 specific malformations. In addition, metoclopramide was not associated with increased risk for having a spontaneous abortion, stillbirth, preterm birth, low-birth-weight infant, or small-for-gestational-age infant.

Allison Bryant, an OB/GYN with NEJM Journal Watch, commented: "For women whose health and quality of life are compromised by nausea, this study provides welcome reassurance about the safety of this medication in pregnancy."

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement